To this day, any photosensitizers for the photodynamic treatment of pulmonary illnesses
have been administered intravenously. There is, however, an intrinsic difficulty in reaching …

Photodynamic inactivation (PDI) is a promising alternative for combating infections caused
by antimicrobial resistant bacteria. Pneumonias are among the most worrisome infections …

Infectious pneumonia is a major cause of morbidity/mortality, mainly because of the
increasing rate of microorganisms resistant to antibiotics. Photodynamic Therapy (PDT) is …

Pulmonary disease is the main cause of morbidity and mortality in cystic fibrosis (CF) suffers,
with multidrug-resistant Pseudomonas aeruginosa and Burkholderia cepacia complex as …

Respiratory disease is the main cause of morbidity and mortality in patients with cystic
fibrosis (CF). In such patients chronic Pseudomonas aeruginosa infection is virtually …

Pneumonia is responsible for high mortality rates around the world, and its major treatment
is based on antibiotic treatment. Antimicrobial resistance has been increasing in the last …

In the context of the rapid increase of antibiotic-resistant infections, in particular of
pneumonia, antimicrobial photodynamic therapy (aPDT), the microbiological application of …

Chronic lung infections are among the most diffused human infections, being often
associated with multidrug-resistant bacteria. In this framework, the European project …

Pneumonia is the main cause of children mortality worldwide, and its major treatment
obstacle stems from the microorganisms increasing development of resistance to several …

Photodynamic therapy (PDT) involves the use of photosensitising agents that are selectively
retained within tumour cells. The agents remain inactive until exposed to light of the proper …